Image

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

Testing ALKS 2680 for adults with Narcolepsy Type 2.

Recruiting
18-70 years
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing a new medicine called ALKS 2680 for people with Narcolepsy Type 2 (NT2), a disorder that makes you feel very sleepy during the day. The study will compare how well ALKS 2680 tablets work against placebo tablets, which look like medicine but have no active drug. Researchers want to see if the new medicine helps reduce daytime sleepiness and other NT2 symptoms.

Narcolepsy Type 2 (NT2) is a condition that causes excessive daytime sleepiness without the sudden muscle weakness (cataplexy) seen in Narcolepsy Type 1. Placebo is a substance with no medicine used in studies to compare effects with the actual drug.

  • Study Length: Check with the research team for the specific duration and number of visits required.
  • Eligibility: Participants must meet specific criteria and cannot have certain other conditions. Pregnant or breastfeeding individuals cannot join.
  • Risks: There may be risks, and your safety is the top priority. Discuss any concerns with the study staff.
Print
Study details
    Narcolepsy Type 2

NCT07502443

Alkermes, Inc.

6 June 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.